Coffee pulp is one of the most underutilised by-products from coffee processing. For coffee growers, disposing of this agro-industrial biomass has become one of the most difficult challenges. This study utilised this potential biomass as raw material for polyphenolic antifungal agents. First, the proportion of biomass was obtained from the Arabica green bean processing. The yield of by-products was recorded, and the high-potency biomass was serially extracted with organic solvents for the polyphenol fraction. Quantification of the polyphenols was performed by High Performance Liquid Chromatography (HPLC), then further confirmed by mass spectrometry modes of the liquid chromatography–quadrupole time-of-flight (QTOF). Then, the fraction was used to test antifungal activities against Alternaria brassicicola, Pestalotiopsis sp. and Paramyrothecium breviseta. The results illustrated that caffeic acid and epigallocatechin gallate represented in the polyphenol fraction actively inhibited these fungi with an inhibitory concentration (IC50) of 0.09, 0.31 and 0.14, respectively. This study is also the first report on the alternative use of natural biocontrol agent of P. breviseta, the pathogen causing leaf spot in the Arabica coffee.

Species of Paramyrothecium that are reported as plant pathogens and cause leaf spot or leaf blight have been reported on many commercial crops worldwide. In 2019, during a survey of fungi causing leaf spots on plants in Chiang Mai and Mae Hong Son provinces, northern Thailand, 16 isolates from 14 host species across nine plant families were collected. A new species Paramyrothecium vignicola sp. nov. was identified based on morphology and concatenated (ITS, cmdA, rpb2, and tub2) phylogeny. Further, P. breviseta and P. foliicola represented novel geographic records to Thailand, while P. eichhorniae represented a novel host record (Psophocarpus sp., Centrosema sp., Aristolochia sp.). These species were confirmed to be the causal agents of the leaf spot disease through pathogenicity assay. Furthermore, cross pathogenicity tests on Coffea arabica L., Commelina benghalensis L., Glycine max (L.) Merr., and Dieffenbachia seguine (Jacq.) Schott revealed multiple host ranges for these pathogens. Further research is required into the host–pathogen relationship of Paramyrothecium species that cause leaf spot and their management. Biotic and abiotic stresses caused by climate change may affect plant health and disease susceptibility. Hence, proper identification and monitoring of fungal communities in the environment are important to understand emerging diseases and for implementation of disease management strategies.

Fruit crops have a pivotal role in Thailand’s economy. Continuous evaluation of 13 potential and emerging diseases in fruit crops is important. Necrotic and discolored leaf spots were observed in Persea americana (avocado) and Mangifera indica (mango). The isolated fungi from the leaf spot were identified through multi-loci phylogenetic analyses using a concatenated matrix of ITS, LSU, tef1α, and tub2. The fungal isolates from Pe. americana were identified as Pseudoplagiostoma perseae, and isolates from Mangifera indica were identified as Ps. mangiferae. The pathogenicity assays confirmed that Ps. perseae causes leaf spots of Pe. americana, while Ps. mangiferae causes leaf blotch of M. indica. The pathogenicity of Ps. perseae and Ps. mangiferae has been reported in China and Taiwan. Hence, this study provides a report of the novel geographical distribution of Ps. perseae and Ps. mangiferae. Moreover, the cross-inoculation tests of Ps. perseae and Ps. mangiferae on M. indica and Pe. americana were conducted, respectively. Both pathogens showed host specificity, as suggested by the phylogenetic relationship and the host plants. In addition, disease control with carbendazim, trifloxystrobin, mancozeb, and prochloraz was assayed. All fungicides equally inhibited the mycelial growth of both pathogens.

In the current study, eleven sooty mold isolates were collected from different tropical host plants. The isolates were identified under Capnodium, Leptoxyphium and Trichomerium, based on morphology and phylogeny. For the secondary metabolite analysis, the isolates were grown on Potato Dextrose Broth (PDB). The well-grown mycelia were filtered and extracted over methanol (MeOH). The metabolites in the growth medium (or filtrate) were extracted over ethyl acetate (EtOAc). The antifungal activities of each crude extract were tested over Alternaria sp., Colletotrichum sp., Curvularia sp., Fusarium sp. and Pestalotiopsis sp. The metabolites were further tested for their total phenolic, flavonoid and protein content prior to their antioxidant and anti-fungal potential evaluation. The MeOH extracts of sooty molds were enriched with proteins and specifically inhibited Curvularia sp. The total phenolic content and 2,2-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) activity was largely recovered from the filtrate corresponding to the inhibition of Alternaria sp.; while the flavonoid and free radical reduction suggested a relative induction of growth of the Fusarium sp., Colletotrichum sp. and Pestalotiopsis sp. Hence, this study reveals the diversity of sooty molds in Thailand by a modern phylogenetic approach. Furthermore, the preliminary screening of the isolates reveals the potential of finding novel compounds and providing insights for the future research on secondary metabolites of bio-trophic fungi and their potential usage on sustainable agriculture.

Mycogenic nanomaterials, nanoparticles (NPs) biosynthesized through fungal enzymatic and metabolic activity, have emerged as a compelling alternative to chemically synthesized nanomaterials, offering fundamental biocompatibility, green production conditions, and biologically functional surface coatings. Fungi, acting as natural “nanofactories,” harness reductases, oxidoreductases, secreted proteins, and secondary metabolites to reduce metal ions into stable NPs under ambient conditions, simultaneously capping the particles with biomolecules that enhance colloidal stability, biocompatibility, and secondary biological activity. Unlike previous reviews that have addressed either biosynthesis mechanisms or applications in isolation, this review uniquely adopts a structured “Promise vs. Barrier” framework across six interconnected thematic pillars, offering the first comprehensive critical synthesis that simultaneously maps mechanistic frontiers, biodiversity gaps, and translational barriers within mycogenic nanotechnology. The present review critically examines both the extraordinary promise and the persistent barriers facing mycogenic nanotechnology across biosynthetic mechanisms, fungal biodiversity, nanomaterial portfolio expansion, biomedical applications, environmental and agricultural utility, and industrial scalability. We highlight how emerging multiomics approaches, integrating transcriptomics, proteomics, and metabolomics, are beginning to decode the molecular blueprints of fungal NP synthesis, while acknowledging that mechanistic knowledge gaps, limited genetic toolkits for non-model fungi, and the absence of standardized protocols continue to impede progress. The fungal kingdom represents a vast, underexplored reservoir of nanofactory potential, with fewer than 1% of known species evaluated to date; strategic bioprospecting using genome mining and machine learning is beginning to unlock this diversity. Mycogenic NPs demonstrate broad-spectrum antimicrobial activity against multidrug-resistant pathogens, selective anticancer activity, biosensing capacity, and applications in wound healing, sustainable agriculture, environmental remediation, and smart food packaging. However, critical deficits persist in clinical validation, long-term toxicity data, manufacturing reproducibility, and regulatory clarity. The review concludes with a tiered roadmap, spanning immediate mechanistic priorities through to long-term synthetic biology and AI-integrated commercialization, and calls for coordinated international action on standardization, reference material development, and harmonized regulatory frameworks to bridge the gap between laboratory promise and real-world application.